Concepedia

High-Dose Platinum versus Standard Dose in Advanced Ovarian Carcinoma: A Randomized Trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC)

Florence Joly, Jean‐François Héron, Pierre Kerbrat, J Chauvergne, Mary Beth Rios, F. Mayer, P. Chinet-Charrot, A Goupil, Daniela Lebrun-Jezekova, D. Vennin,

Gynecologic Oncology · 2000 · 27 citations · 34 references

DOI

Concepts

References

34

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

, , +16

Important Advances in Oncology

Vincent T. DeVita, S Hellman, S A Rosenberg · Anti-Cancer Drugs · 1991 · 762 citations

, , +3

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.

Graham J. Kemp, Peter S. Rose, John R. Lurain et al. · Journal of Clinical Oncology · 1996 · 469 citations

, , +17

The importance of dose intensity in the outcome of chemotherapy.

Hryniuk Wm · PubMed · 1988 · 262 citations

, , +12

Survival of European women with gynaecological tumours, during the period 1978–1989

Gemma Gatta, Magdalena B Lasota, A Verdecchia · European Journal of Cancer · 1998 · 249 citations

, , +10